Literature DB >> 22977513

'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.

Pascale Quatresooz1, Marie-Annick Reginster, Gérald E Piérard.   

Abstract

Cutaneous malignant melanoma (MM) is rooted in the dermal connective tissue, which consists of apparently unremarkable stromal cells as they appear upon regular histopathological examination. However, a number of in vitro studies have shown that these cells produce diverse types of cytokines, growth factors and enzymes in excess. In addition, they store and probably release various structural components of the extracellular matrix (ECM). Most of the current information comes from in vitro experiments, and these findings do not always correlate with investigations carried out using excised human MM tissue. The MM-stroma connection appears crucial to the regulation of neoplastic growth, invasiveness and initial metastatic spread. However, little is known about the in vivo intracellular storage and extracellular deposits of specific ECM macromolecules located inside and around MM lesions. This review summarizes various distinct features of the peri-MM stroma, which shows an intracytoplasmic abundance of Factor XIIIa, versican and various α (IV) collagen chains. The area exhibiting such changes corresponds to the location where neoangiogenesis commonly develops and where extravascular unicellular metastatic MM lesions are possibly found. Some of these inconspicuous migratory malignant melanocytes may actually correspond to MM stem cells. Their presence was found to be significantly associated with an increased risk for distant metastases, particularly in the sentinel lymph nodes. Although much remains to be learned, active intervention of the ECM appears likely in the inconspicuous early dermal metastatic migration of MM cells.

Entities:  

Year:  2011        PMID: 22977513      PMCID: PMC3440745          DOI: 10.3892/etm.2011.221

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  65 in total

1.  Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells.

Authors:  F Nozawa; M Hirota; A Okabe; M Shibata; T Iwamura; Y Haga; M Ogawa
Journal:  J Surg Res       Date:  2000-12       Impact factor: 2.192

2.  Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation.

Authors:  M Brenner; K Degitz; R Besch; C Berking
Journal:  Br J Dermatol       Date:  2005-10       Impact factor: 9.302

3.  Increased expression of stem cell markers in malignant melanoma.

Authors:  Walter M Klein; Bryan P Wu; Shuping Zhao; Hong Wu; Andres J P Klein-Szanto; Steven R Tahan
Journal:  Mod Pathol       Date:  2006-11-24       Impact factor: 7.842

Review 4.  The multiple roles of tumour stroma.

Authors:  N Wernert
Journal:  Virchows Arch       Date:  1997-06       Impact factor: 4.064

5.  Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin.

Authors:  C Lugassy; G R Dickersin; L Christensen; T Karaoli; M LeCharpentier; J P Escande; R L Barnhill
Journal:  J Cutan Pathol       Date:  1999-02       Impact factor: 1.587

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas.

Authors:  R S Kerbel; H Kobayashi; C H Graham; C Lu
Journal:  J Investig Dermatol Symp Proc       Date:  1996-04

Review 8.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

9.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Authors:  Soledad R Alonso; Pablo Ortiz; Marina Pollán; Beatriz Pérez-Gómez; Lydia Sánchez; Ma Jesús Acuña; Raquel Pajares; Francisco J Martínez-Tello; Carlos M Hortelano; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Reciprocal effects of ascorbate on cancer cell growth and the expression of matrix metalloproteinases and transforming growth factor-beta.

Authors:  Neena Philips; Thomas Keller; Carol Holmes
Journal:  Cancer Lett       Date:  2007-06-28       Impact factor: 8.679

View more
  6 in total

1.  Molecular dermatopathology in malignant melanoma.

Authors:  Marie-Annick Reginster; Claudine Pierard-Franchimont; Gérald E Piérard; Pascale Quatresooz
Journal:  Dermatol Res Pract       Date:  2011-10-20

2.  Ipilimumab, a promising immunotherapy with increased overall survival in metastatic melanoma?

Authors:  Gérald E Piérard; François Aubin; Philippe Humbert
Journal:  Dermatol Res Pract       Date:  2011-10-23

3.  Thigmotropism of malignant melanoma cells.

Authors:  Pascale Quatresooz; Claudine Piérard-Franchimont; Fanchon Noël; Gérald E Piérard
Journal:  Dermatol Res Pract       Date:  2011-11-17

4.  Smouldering malignant melanoma and metastatic dormancy: an update and review.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Marie-Annick Reginster; Pascale Quatresooz
Journal:  Dermatol Res Pract       Date:  2011-11-02

5.  Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.

Authors:  G E Piérard
Journal:  ISRN Dermatol       Date:  2012-01-11

6.  Malignant melanoma and its stromal nonimmune microecosystem.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  J Oncol       Date:  2012-06-28       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.